Schols Saskia E M, Tick Lidwine L W
Department of Hematology, Internal Medicine, Maastricht University Medical Center, Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
Department of Internal Medicine, Máxima Medical Centre, De Run 4600, 5504 DB, Veldhoven, The Netherlands.
J Med Case Rep. 2015 Feb 19;9:37. doi: 10.1186/s13256-014-0506-3.
The gross majority of extramedullary plasmacytomas arise in the lymphatic tissue of the upper respiratory tract. On average, one third of patients with a solid plasmacytoma will develop multiple myeloma, resulting in a worse clinical outcome. We describe a case of rapid recurrent extramedullary plasmacytomas in the background of an asymptomatic multiple myeloma.
A 71-year-old, white Caucasian woman presented with three extramedullary plasmacytomas occurring within a short time period. The third plasmacytoma was accompanied by progressive cervical pain and swallow dysfunction. Additional immunostaining test results were negative for CD56 and showed high MIB-1 expression in the extramedullary plasmacytoma and low MIB-1 expression in the bone marrow. A conventional swallow X-ray did not show any obstruction, however a magnetic resonance imaging scan of her cervical backbone revealed an extramedullary plasmacytoma, threatening her spinal cord. A short course of radiation therapy alleviated her pain and during almost a two-year follow-up period, the multiple myeloma remained asymptomatic, despite the rise in immunoglobulin A lambda levels. After the appearance of the third plasmacytoma, systemic chemotherapy was started to prevent the development of a fourth plasmacytoma, despite the asymptomatic character of the multiple myeloma.
In this case report we describe the rapid appearance of extramedullary plasmacytomas in the background of an asymptomatic multiple myeloma. An immunohistochemical analysis was negative for CD56 and showed high MIB-1 expression in the extramedullary plasmacytoma and low MIB-1 expression in the bone marrow, contributing to the potential underlying pathophysiology of the recurrent extramedullary plasmacytomas and their genetic changes. Systemic chemotherapy was started and no fourth extramedullary plasmacytoma has developed since.
绝大多数髓外浆细胞瘤发生在上呼吸道淋巴组织。平均而言,三分之一的实体性浆细胞瘤患者会发展为多发性骨髓瘤,导致更差的临床结局。我们描述了一例在无症状多发性骨髓瘤背景下快速复发的髓外浆细胞瘤病例。
一名71岁的白人女性出现了在短时间内发生的三处髓外浆细胞瘤。第三处浆细胞瘤伴有进行性颈部疼痛和吞咽功能障碍。额外的免疫组化检测结果显示CD56为阴性,髓外浆细胞瘤中MIB-1表达高,骨髓中MIB-1表达低。传统的吞咽X线检查未显示任何梗阻,但颈椎磁共振成像扫描显示有一处髓外浆细胞瘤,危及脊髓。短疗程放疗缓解了她的疼痛,在近两年的随访期间,尽管免疫球蛋白A λ水平升高,但多发性骨髓瘤仍无症状。在第三处浆细胞瘤出现后,尽管多发性骨髓瘤无症状,仍开始进行全身化疗以预防第四处浆细胞瘤的发生。
在本病例报告中,我们描述了在无症状多发性骨髓瘤背景下髓外浆细胞瘤的快速出现。免疫组化分析显示CD56为阴性,髓外浆细胞瘤中MIB-1表达高,骨髓中MIB-1表达低,这有助于复发性髓外浆细胞瘤及其基因变化的潜在病理生理学研究。已开始进行全身化疗,此后未出现第四处髓外浆细胞瘤。